Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126063361 | 12606336 | 1 | I | 20160323 | 20160722 | 20160729 | 20160729 | EXP | JP-ROCHE-1805224 | ROCHE | 70.00 | YR | M | Y | 0.00000 | 20160729 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126063361 | 12606336 | 1 | PS | COPEGUS | RIBAVIRIN | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | 21511 | 600 | MG | TABLET | |||||||
126063361 | 12606336 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | 0 | 400 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126063361 | 12606336 | 1 | Hepatic cirrhosis |
126063361 | 12606336 | 2 | Hepatic cirrhosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126063361 | 12606336 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126063361 | 12606336 | Drug ineffective | |
126063361 | 12606336 | Hepatitis C | |
126063361 | 12606336 | Hepatocellular carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126063361 | 12606336 | 1 | 20151202 | 20160223 | 0 | |
126063361 | 12606336 | 2 | 20151202 | 20160223 | 0 |